TVARDI THERAPEUTICS, INC. (TVRD) Net margin 2016–2024
TVARDI THERAPEUTICS, INC. (TVRD) net profit margin by fiscal year — reported net income divided by reported revenue.
-411.9%FY2024 · since FY2016: -66604.7% → -411.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -411.9% | +153.3 pp |
| FY2023 | -565.2% | -361.1 pp |
| FY2022 | -204.2% | +179.9 pp |
| FY2021 | -384.1% | -390.3 pp |
| FY2020 | 6.2% | +541.1 pp |
| FY2019 | -534.9% | +14.6 pp |
| FY2018 | -549.5% | +5830.8 pp |
| FY2017 | -6380.4% | +60224.3 pp |
| FY2016 | -66604.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TVRD financial trends
TVRD RevenueTVRD Net incomeTVRD Gross profitTVRD Gross marginTVRD Operating incomeTVRD Operating marginTVRD Operating cash flowTVRD Free cash flowTVRD Capital expendituresTVRD Return on equityTVRD Stock buybacksTVRD Dividends paidTVRD Total assetsTVRD Total liabilitiesTVRD Shareholders’ equityTVRD overview →